Patents Assigned to Cytosignet, Inc.
  • Patent number: 9012157
    Abstract: Provided is a method for determining immunoglobulins in a neonatal ungulate. The method entails obtaining a sample of oral secretions from the neonatal ungulate and measuring an amount of immunoglobulins in the sample of oral secretions. The method is faster and more convenient than previously available methods for determining immunglobulins in neonatal ungulates, such as neonatal horses and cattle.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: April 21, 2015
    Assignee: Cytosignet, Inc.
    Inventor: Nathan L. Smith
  • Patent number: 8877451
    Abstract: This invention provides compositions and methods for detection of hematophagous ectoparasitic activity in an enclosure or area. The compositions comprise a reagent or reagents which are reactive against antigens or markers as they appear in the excrement or other ectoparasitic materials. Such markers or antigens may be produced by the ectoparasite itself or may have been introduced into the ectoparasite because of its blood feeding activity. The method of the present invention comprises collecting from the enclosure or area, a sample comprising environmental dust or materials and subjecting the sample to tests for detecting the presence of hematophagous ectoparasitic markers, host markers or both.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: November 4, 2014
    Assignee: Cytosignet, Inc.
    Inventor: Nathan L. Smith
  • Publication number: 20140086902
    Abstract: Provided is a method for determining immunoglobulins in a neonatal ungulate. The method entails obtaining a sample of oral secretions from the neonatal ungulate and measuring an amount of immunoglobulins in the sample of oral secretions. The method is faster and more convenient than previously available methods for determining immunglobulins in neonatal ungulates, such as neonatal horses and cattle.
    Type: Application
    Filed: December 2, 2013
    Publication date: March 27, 2014
    Applicant: CYTOSIGNET, INC.
    Inventor: Nathan L. Smith
  • Patent number: 8597894
    Abstract: Provided is a method for determining immunoglobulins in a neonatal ungulate. The method entails obtaining a sample of oral secretions from the neonatal ungulate and measuring an amount of immunoglobulins in the sample of oral secretions. The method is faster and more convenient than previously available methods for determining immunglobulins in neonatal ungulates, such as neonatal horses and cattle.
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: December 3, 2013
    Assignee: Cytosignet, Inc.
    Inventor: Nathan L. Smith
  • Publication number: 20130183682
    Abstract: This invention provides compositions and methods for detection of hematophagous ectoparasitic activity in an enclosure or area. The compositions comprise a reagent or reagents which are reactive against antigens or markers as they appear in the excrement or other ectoparasitic materials. Such markers or antigens may be produced by the ectoparasite itself or may have been introduced into the ectoparasite because of its blood feeding activity. The method of the present invention comprises collecting from the enclosure or area, a sample comprising environmental dust or materials and subjecting the sample to tests for detecting the presence of hematophagous ectoparasitic markers, host markers or both.
    Type: Application
    Filed: March 12, 2013
    Publication date: July 18, 2013
    Applicant: CYTOSIGNET, INC.
    Inventor: Cytosignet, Inc.
  • Publication number: 20130149728
    Abstract: Provided are methods and devices used for determining the presence or absence of a contaminant in the sample of oral fluid. The method involves contacting a substrate having a detectable reporter with a sample of oral fluid and, based on determining a signal from the detectable reporter determining the presence or absence of a contaminant in the sample of oral fluid. The invention is useful for detecting lactose, milk, colostrum, blood, hemoglobin, whole cells, and combinations thereof. The method can be used for detecting oral contaminants in oral fluid samples obtained from any mammal, including neonatal ungulates.
    Type: Application
    Filed: December 7, 2012
    Publication date: June 13, 2013
    Applicant: CYTOSIGNET, INC.
    Inventor: Cytosignet, Inc.
  • Patent number: 8460890
    Abstract: This invention provides compositions and methods for detection of hematophagous ectoparasitic activity in an enclosure or area. The compositions comprise a reagent or reagents which are reactive against antigens or markers as they appear in the excrement or other ectoparasitic materials. Such markers or antigens may be produced by the ectoparasite itself or may have been introduced into the ectoparasite because of its blood feeding activity. The method of the present invention comprises collecting from the enclosure or area, a sample comprising environmental dust or materials and subjecting the sample to tests for detecting the presence of hematophagous ectoparasitic markers, host markers or both.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: June 11, 2013
    Assignee: Cytosignet, Inc.
    Inventor: Nathan L. Smith
  • Patent number: 7727734
    Abstract: This invention provides compositions and methods for detection of hematophagous ectoparasitic activity in an enclosure or area. The compositions comprise a reagent or reagents which are reactive against antigens or markers as they appear in the excrement or other ectoparasitic materials. Such markers or antigens may be produced by the ectoparasite itself or may have been introduced into the ectoparasite because of its blood feeding activity. The method of the present invention comprises collecting from the enclosure or area, a sample comprising environmental dust or materials and subjecting the sample to tests for detecting the presence of hematophagous ectoparasitic markers, host markers or both.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: June 1, 2010
    Assignee: CytoSignet, Inc.
    Inventor: Nathan L. Smith
  • Patent number: 5494800
    Abstract: A method of determining the presence and quantity of an analyte of interest in a particulate-containing sample is disclosed, as is a construct for use in the method. The method is particularly useful for determining an analyte in whole blood and in fermentation suspensions. The construct is comprised of a first moiety, which is a particulate-binding moiety and a second moiety, which binds the analyte of interest.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: February 27, 1996
    Assignee: CytoSignet, Inc.
    Inventor: Nathan L. Smith, III
  • Patent number: 4900685
    Abstract: A method of determining the presence and quantity of an analyte of interest in a particulate-containing sample is disclosed, as is a construct for use in the method. The method is particularly useful for determining an analyte in whole blood and in fermentation suspensions. The construct is comprised of a first moiety, which is a particulate-binding moiety and a second moiety, which binds the analyte of interest.
    Type: Grant
    Filed: January 29, 1987
    Date of Patent: February 13, 1990
    Assignee: Cytosignet, Inc.
    Inventor: Nathan L. Smith, III